I am doing in vitro matrix degradation assay with Enatmoeba histolytica and I observe different behavior of the pathogen towards two different components of the ECM viz Fibronectin and collagen type I. The pathogen infects the intestine and in severe infections can breach the mucosal lining of the gut and escape to the liver causing liver abscess but still persons infected with it can also act as asymptomatic carriers and some people show severe infection with the infection flaring up and causing massive tissue damage.

So, can the ECM composition trigger such kind of response, which can vary from one person to the other?

Similar questions and discussions